An international team of researchers has determined that a popular drug manufactured by Merck to treat COVID-19 is driving what is being described as “unintended” mutations in the virus and potentially fueling the virus’s spread.
The Express reported Monday that these researchers studied a whopping 15 million COVID-19 sequences to determine how it has mutated over time. What they found could be described as alarming.
Their analysis shows that there were mutations that deviated from the normal pattern of change. Moreover, one-third of the mutations were associated with individuals who had taken the popular antiviral drug molnupiravir.
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr